Cranial Osteopathic Techniques on the Symptoms of Benign Paroxysmal Positional Vertigo
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03854084 |
|
Recruitment Status :
Completed
First Posted : February 26, 2019
Last Update Posted : February 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Benign Paroxysmal Positional Vertigo | Other: The cranial osteopathic techniques Other: Control group | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 20 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effect of the Cranial Osteopathic Techniques on the Symptoms of Benign Paroxysmal Positional Vertigo |
| Actual Study Start Date : | December 14, 2017 |
| Actual Primary Completion Date : | March 23, 2018 |
| Actual Study Completion Date : | March 23, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention group
The cranial osteopathic techniques
|
Other: The cranial osteopathic techniques
Technique of the temporal bones in favor of the free movement. Ear Pull technique: the hands of the osteopath holds the auricle of the individual with the thumb, index and the middle finger in a tweezer shape and with the elbows resting over the stretcher. Ruddy technique: The osteopath puts the thumbs on the eyelid of each eyeball. |
|
Sham Comparator: control group
Control group
|
Other: Control group
Simulation of the techniques was used in the interventional group |
- Dix-Hallpike test [ Time Frame: 5 weeks ]consists in provoke a sudden change of position: with the eyes open and looking forward; shifts quickly from the sitting position with the head leaning 45 degrees to one of the sides, with the head hanging. Sits again and perform the same procedure to the opposite side. The maneuver is executed initially to the side where the patient related dizziness while the change of the position of the head. When the individual is not able to recognize in which side the dizziness occurs, the investigators have begun the maneuver on the right side, in order to standardize the test. All the stages of the test must be performed with 40 seconds gap (CAMPOS et al., 2006; HERDMAN; 2003).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Were included in the study male and female individuals with age range between 25 and 45 years, BPPV positives.
Exclusion Criteria:
- The exclusion criteria were being in use of any medication for vertigo treatment and the presence of any infectious pathology or deformity in the inner ear.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03854084
| Brazil | |
| Laiana Sepúlveda de Andrade Mesquita | |
| Teresina, Piauí, Brazil, 64052-580 | |
| Responsible Party: | Laiana Sepúlveda de Andrade Mesquita, Senior Researcher, Universidade Estadual do PiauÍ |
| ClinicalTrials.gov Identifier: | NCT03854084 |
| Other Study ID Numbers: |
FDAAA 801 |
| First Posted: | February 26, 2019 Key Record Dates |
| Last Update Posted: | February 26, 2019 |
| Last Verified: | February 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Vertigo Benign Paroxysmal Positional Vertigo Dizziness Vestibular Diseases Labyrinth Diseases |
Ear Diseases Otorhinolaryngologic Diseases Neurologic Manifestations Nervous System Diseases Sensation Disorders |

